Skip to main content
HCPCS J0165 · Level II · Part B drug

J0165: epinephrine, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J0165

Billing unit
0.1 MG
Inj epinephrine nos 0.1 mg
ASP payment limit
$0.206
October 2026; -12.0% vs July 2026
Practitioner MUE
20
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J0165 is the Level II code for Injection, epinephrine, not otherwise specified, 0.1 mg, billed per 0.1 MG. The Medicare Part B ASP payment limit for October 2026 is $0.206 per billing unit, down 12.0% from July 2026. The practitioner MUE allows up to 20 units per date of service (MAI 3), so a full 20-unit day is $4.12 at the current limit. Under OPPS it carries status indicator N. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. Other HCPCS codes whose descriptor names epinephrine: J0166 (the BPI product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0165); J0167 (the Hospira product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0165); J0162 (the Fresenius product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0165); J0168 (the International Medication Systems product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0165); J0169 (Adrenalin; not therapeutically equivalent to J0165). The ASP crosswalk maps 7 NDCs to it, sold as Epinephrine HCl, Epinephrine by American Regent, Inc., Endo USA, Inc., A-S Medication Solutions. No current Billing and Coding Article lists J0165, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J0165 at $0.206 per 0.1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.234 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J0165
QuarterPayment limitPerCoinsurance
October 2026$0.2060.1 MG20%
July 2026$0.2340.1 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 7 NDCs from 4 labelers to J0165. Report the NDC in the claim's drug segment and bill the number of J0165 units that equals the quantity administered divided by 0.1 MG; the last column gives units per full package.

NDCs that crosswalk to J0165
NDCDrug nameLabelerPackage sizeBilling units / package
00517-3030-01Epinephrine HClAmerican Regent, Inc.30 × 1300
42023-0168-01Epinephrine HClEndo USA, Inc.30 × 1300
42023-0168-89Epinephrine HClEndo USA, Inc.30 × 1300
42023-0168-99Epinephrine HClEndo USA, Inc.30 × 1300
50090-2058-00Epinephrine HClA-S Medication Solutions10 × 10100
50090-5569-00Epinephrine HClA-S Medication Solutions10 × 10100
70121-1660-02EpinephrineAmneal Pharmaceuticals, LLC30 × 1300

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J0165. For practitioners the limit is 20 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J0165 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services203 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital1203 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J0165 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J0165 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J0165 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J0165 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J0165 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J0165 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Common denials for J0165 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J0165

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J0165

What does HCPCS code J0165 describe?

J0165 is defined by CMS as "Injection, epinephrine, not otherwise specified, 0.1 mg". Each billing unit represents 0.1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J0165 a CPT code?

No. J0165 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as epinephrine; CPT codes are five-character codes maintained by the AMA. On a Part B claim J0165 reports the drug itself in 0.1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J0165 in October 2026?

The ASP-based payment limit is $0.206 per 0.1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.234. Commercial payers use their own fee schedules.

How many units of J0165 can be billed per day?

The practitioner Medically Unlikely Edit is 20 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 120. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J0165?

The October 2026 ASP crosswalk lists 7 NDCs from 4 labelers: Epinephrine HCl (American Regent, Inc.); Epinephrine HCl (Endo USA, Inc.); Epinephrine HCl (A-S Medication Solutions); Epinephrine (Amneal Pharmaceuticals, LLC). For example NDC 00517-3030-01 (package size 30) equals 300 billing units of J0165.

Does J0165 have NCCI bundling edits?

No active practitioner PTP pairs list J0165 as a column-1 or column-2 code in the v323r0 release.

J0165 vs J0166: what is the difference?

Both are HCPCS Level II codes whose descriptor names epinephrine. What sets J0166 apart: the BPI product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0165. J0165 is billed per 0.1 mg, limit $0.206, MUE 20; J0166 is billed per 0.1 mg, limit $0.83, MUE 20. Report the code whose descriptor matches the product and setting in the record.

J0165 vs J0167: what is the difference?

Both are HCPCS Level II codes whose descriptor names epinephrine. What sets J0167 apart: the Hospira product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0165. J0165 is billed per 0.1 mg, limit $0.206, MUE 20; J0167 is billed per 0.1 mg, limit $1.422, MUE 20. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.